Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Cardiotoxicity|Breast Cancer
Interventions: DRUG: Rosuvastatin 20mg
Sponsor: Tanta University